Celularity Inc (CELU) Stock Price & Analysis

Celularity Inc (CELU) rose 0.00% to USD 0.75 as of July 26, 2026 at 11:53 UTC, according to Nexqual real-time market data.

CELU last closed at USD 0.75; the session ranged USD 0.75–0.82 on volume of 48,047 shares. Market capitalization is —, with a 52-week range of USD 0.56–4.31 (NCM). Source: Nexqual, July 26, 2026 at 11:53 UTC.

Key Statistics (as of July 26, 2026 at 11:53 UTC)

Technical Analysis (CELU)

Nexqual's technical model rates CELU "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 26, 2026 at 11:53 UTC.

From Celularity Inc's Latest SEC 10-K Filing (filed 2026-04-30)

Key Strengths & Strategy (as disclosed to the SEC)

• We have developed and acquired proprietary technology for collecting, processing, and storing placental stem cells with potentially broad therapeutic applications in the treatment of aging-associated and other degenerative disorders and diseases.
• Utilizing our Celularity IMPACT platform, our proprietary process has mitigated these limitations by expanding and differentiating placental-derived stem cells into NK cells over a period of 35 days.
• We use our proprietary Celularity IMPACT platform for the development of allogeneic cellular therapies that we believe exert immunomodulatory and regenerative effects.
• Donors providing birth materials do not encounter any fees and are not renumerated.   Licensed health care professionals collect donor material utilizing our proprietary collection kits, which include barcode labels for biomaterials (cord blood, placenta, and maternal blood samples) along with appropriate chain of custody documentation.

Partnerships

• Hoffmann-La Roche AG.   Many of our competitors, either alone or with their collaboration partners, have significantly greater financial resources and expertise in research and development, preclinical testing, clinical trials, manufacturing, and marketing than we do.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 11:53 UTC. This page is informational and not investment advice.